For his seminal work on elucidating key molecular-scale mechanisms that govern biogeochemical transformation of contaminants, trace metals, and natural organic matter, which has made significant contributions to the understanding of natural organic and metal cycling in terrestrial ecosystems and remediation of contaminated sites, and also for his contributions to the development of the next generation of scientists and engineers.
Filter Corporate Fellows
Corporate Fellow Type
Year
- (-) 2017 (2)
- (-) 2009 (1)
- (-) 2007 (1)
- (-) 2006 (1)
- (-) 2005 (1)
- (-) 2001 (1)
- (-) 1998 (1)
- (-) 1988 (1)
- 2023 (4)
- 2022 (2)
- 2021 (2)
- 2020 (4)
- 2016 (1)
- 2015 (1)
- 2014 (1)
- 2013 (3)
- 2012 (2)
- 2011 (2)
- 2008 (2)
- 2004 (1)
- 2003 (2)
- 2002 (2)
- 2000 (1)
- 1999 (2)
- 1996 (1)
- 1992 (1)
- 1991 (1)
- 1985 (1)
- 1983 (1)
- 1979 (1)
All Corporate Fellow summaries reflect the awardee and ORNL at the time the fellowship was awarded.
2017
For pioneering advances in the field of materials chemistry for the design, synthesis and fabrication of new materials and their translation into new energy technologies, including superconductor wires, electrodes for batteries, solar cells, lithium extraction from geothermal brine and additive manufacturing of magnets, and also for his leadership in developing the next generation of scientists and engineers.
2009
For far-reaching accomplishments on national security issues relating to nuclear weapons proliferation, security of nuclear materials, and counterterrorism.
2007
For his pioneering contributions to the study of nonequilibrium systems, quantum magnetism, and excitations in condensed matter.
2006
For contributions to high-performance networking and multiple-sensor fusion and for developing a unifying theory of information fusion.
2005
For research in the fields of astrophysics and supernova science.
2001
For his internationally recognized accomplishments in high-energy physics, radiation transport, and detector and neutron target research and development.
1998
For international leadership in developing innovative therapeutic and diagnostic applications of radionuclides for nuclear medicine.
1988
For advances in protein structure and enzyme mechanisms by use of affinity labeling and site-directed mutagenesis.